Form D · Biotechnology
BlueWillow Biologics, Inc.
Ann Arbor, MI · CIK 0001172083
Offering snapshot reported Feb 12, 2024 · SEC filing
- Reported sold
- $850K Offering amount: $3M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2024 | Initial | $850,000 | No comparison | 2 | SEC filing |
| Oct 14, 2022 | Initial | $5,895,312 | No comparison | 16 | SEC filing |
| Apr 8, 2020 | Initial | $8,190,705 | No comparison | 19 | SEC filing |
| Sep 5, 2019 | Initial | $800,000 | No comparison | 4 | SEC filing |
| May 30, 2018 | Initial | $6,709,819 | No comparison | 17 | SEC filing |
| Feb 15, 2017 | Initial | $775,000 | No comparison | 5 | SEC filing |
| Feb 4, 2016 | Initial | $1,800,000 | No comparison | 6 | SEC filing |
| May 29, 2009 | Amendment | $10,000,000 | No comparison | Not reported | SEC filing |
| Dec 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 13, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-504948
Source: Form D, filed Feb 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Arida | Executive |
| James R. Baker, Jr. | Director |
| Hugo Braun | Director |
| Gary Costley | Director |
| Chad Costley | Director, Executive |
| Ronald M. Cresswell | Director |
| Roger D'orazio | Director |
| Daniel B. Dubin | Director |
| Angela Harris | Director |
| Robert C. Moellering | Director |
| David Peralta | Director, Executive |
| Norman C. Selby | Director |
| David M. Stout | Director |
| Peter Ulrich | Director |
| Phil Wilmington | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2311 Green Road Suite A
Ann Arbor, MI, 48105
Ann Arbor, MI, 48105